SEC Filing Summary: ADVENTRX Pharmaceuticals, Inc. (Form 8-K)
Business Context and Reporting Period
ADVENTRX Pharmaceuticals, Inc. filed this Current Report on Form 8-K on March 16, 2010. The filing announces the Company's financial results for the three months and the full year ended December 31, 2009. The report references a press release (Exhibit 99.1) containing these results and pro forma financial information reflecting a January 2010 equity financing.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) which is not included in the provided text. The Company notes that the press release includes non-GAAP pro forma information intended to evaluate the effective cash position following the January 2010 financing.
Material Changes
The filing highlights a material event: an equity financing completed in January 2010. Management utilizes pro forma financial data to assess the Company's financial position entering 2010 and to budget for 2010 operations. No specific comparative year-over-year changes are detailed in the 8-K text itself.
Guidance, Outlook, and Risks
Management commentary indicates that the pro forma information is used for budgeting 2010 operations. The filing explicitly states that the pro forma data is not defined by GAAP and should not be considered a substitute for GAAP measures. Reconciliations between GAAP and pro forma information are provided in the attached press release. The filing includes a standard disclaimer that the information is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP financial results for the three months and year ended December 31, 2009.
- Examine the reconciliation between GAAP and non-GAAP pro forma financial information to understand the impact of the January 2010 equity financing.
- Verify the actual cash position and liquidity metrics post-financing as detailed in the press release.
- Confirm the terms and proceeds of the January 2010 equity financing referenced in the pro forma calculations.